Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05942248 · ClinicalTrials.gov registry record · NA
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
A NA study of Acne and Rosacea, sponsored by Integrative Skin Science and Research.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05942248: Recruiting NA study of Acne and Rosacea, sponsored by Integrative Skin Science and Research.
NCT05942248 is a NA study of Acne and Rosacea that is actively recruiting participants, run by Integrative Skin Science and Research. The registered enrollment target is 150 participants, roughly in line with the 137-participant average among 26 other Acne trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05942248, a NA study of Acne and Rosacea, is actively recruiting participants, sponsored by Integrative Skin Science and Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (1)
California
- Integrative Skin and Research - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-06-06 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
What NCT05942248 shows while recruiting
NCT05942248 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 137-participant average among 26 other Acne trials with a reported enrollment target.
The record links to 4 conditions, with Acne appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT05942248 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05942248 about?
NCT05942248 is a clinical study titled "The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis". The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.
What is the current status of trial NCT05942248?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-06-06. Estimated completion is 2025-02-28.
What conditions does trial NCT05942248 study?
This clinical trial studies the following conditions: Acne, Rosacea, Melasma, Seborrheic Dermatitis.
What interventions are being tested in trial NCT05942248?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT05942248?
This trial is sponsored by Integrative Skin Science and Research, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05942248 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05942248's enrollment target sits among peer trials
150 6th of 26 higher than 21 of 26 other Acne trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
-
The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
COMPLETED · NA
-
An Exploratory Investigation of a Male Focused Skincare Supplement
COMPLETED · NA
-
An Exploratory Investigation of a Novel Skincare Regimen
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI